Table 1.
Characteristics in patients with T2D under antidiabetic therapy (stratified by CAD status; CAD = cases, non-CAD = controls).
| Characteristic | CAD n = 26 |
Non-CAD n = 31 |
p valuea |
|---|---|---|---|
| Age (years) | 70.0 ± 9.9 | 55.1 ± 13.2 | 1.01E-04 |
| Males/females (n/n) | 20/6 | 18/13 | |
| BMI (kg/m2) | 31.4 ± 4.3 | 36.3 ± 8.7 | 0.054 |
| Diabetes duration (years) | 18.0 ± 12.7 | 11.5 ± 7.6 | 0.065 |
| HbA1c (%) | 7.81 ± 1.20 | 8.85 ± 1.80 | 0.156 |
| Proinsulin (pmol/l) | 14.7 ± 19.2 | 13.3 ± 7.4 | 0.146 |
| C-peptide (pmol/l) | 1519.2 ± 1202.9 | 1473.5 ± 939.0 | 0.654 |
| SBP (mmHg) | 129.5 ± 13.2 | 129.4 ± 13.8 | 0.949 |
| DBP (mmHg) | 70.5 ± 12.6 | 77.4 ± 10.4 | 0.013 |
| TG (mg/dl) | 215.2 ± 156.3 | 205.8 ± 141.2 | 0.423 |
| Total cholesterol (mg/dl) | 167.5 ± 39.4 | 189.1 ± 35.5 | 5.84E-03 |
| HDL cholesterol (mg/dl) | 38.6 ± 8.9 | 45.7 ± 24.8 | 0.251 |
| LDL cholesterol (mg/dl) | 95.1 ± 27.3 | 111.3 ± 35.7 | 0.018 |
| Albumin (mg/l) | 16.4 ± 36.6 | 25.9 ± 39.1 | 0.082 |
| Creatinine (mg/dl) | 1.33 ± 0.52 | 1.07 ± 0.50 | 0.012 |
| Urea (mg/dl) | 61.6 ± 42.5 | 42.9 ± 18.8 | 0.037 |
| GFR (ml/min) | 60.4 ± 23.2 | 79.8 ± 29.5 | 9.21E-03 |
| Creatine kinase (U/l) | 128.8 ± 79.3 | 174.4 ± 172.7 | 0.642 |
| CRP (mg/dl) | 1.51 ± 2.66 | 2.12 ± 4.84 | 0.438 |
| Lp(a) (mg/dl) | 22.8 ± 31.8 | 40.0 ± 51.7 | 0.494 |
| BNP (pg/ml) | 136.5 ± 178.5 | 30.9 ± 30.6 | 4.68E-06 |
Data shown as mean ± SD.
a p value for comparing patients with CAD and without CAD using Mann-Whitney U test.